Antagonism by neuroleptics of abnormal behavior induced by activation of brain dopamine receptors.
D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D002415:Cats; D002421:Caudate Nucleus / Q000187:drug effects; D003913:Dextroamphetamine / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000037:antagonists & inhibitors; D004298:Dopamine / Q000494:pharmacology / Q000502:physiology*; D018492:Dopamine Antagonists; D006220:Haloperidol / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D012919:Social Behavior / Q000187:drug effects; D013859:Thiocarbamates / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000494:pharmacology*
D018492:Dopamine Antagonists; D011941:Receptors, Adrenergic; D013859:Thiocarbamates; D014149:Tranquilizing Agents; D004295:Dihydroxyphenylalanine; D000661:Amphetamine; D006220:Haloperidol; D001058:Apomorphine; D003913:Dextroamphetamine; D004298:Dopamine